Track topics on Twitter Track topics that are important to you
Syphilis is a sexually transmitted disease caused by the spirochetal bacteria Treponema pallidum subspecies pallidum. The primary route of transmission of syphilis is through sexual contact however ...
Friday, February 13, 2015 - Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydroch...
Irish over-the-counter (OTC) firm Actavis has launched Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride), a once-daily, fixed-dose combination of memantine hydrochloride ...
Actavis announced that NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride), a once-daily, fixed-dose combination of memantine hydrochloride extended-release (a NMDA rece...
Alliance Healthcare has set up a contingency ordering procedure for the following Sanofi products: Cholestagel (colesevelam hydrochloride); Insuman (human insulin) basal, comb and rapid; Lantus (insul...
Dr Graeme M. Lipper summarizes the results of a study comparing clindamycin and TMP-SMX. Medscape Dermatology
Sagent Pharmaceuticals has launched vancomycin hydrochloride for injection, USP, an anti-infective, in a 10 gram preservative-free pharmacy bulk package presentation.
WASHINGTON (dpa-AFX) - Actavis plc (ACT) said Monday that NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride), a once-daily, fixed-dose combination of memantine hydroch...
US-based Sagent Pharmaceuticals has introduced Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 10g preservative-free pharmacy bulk package.
Many drugs can cause neuromuscular blockade. Clindamycin-related neuromuscular blockade is commonly reported, but fatal clindamycin-induced neuromuscular blockade is rarely reported. We describe a 47-...
Benzydamine hydrochloride is a locally acting nonsteroidal anti-inflammatory drug. Benzydamine hydrochloride overdose can cause stimulation of central nervous system, hallucinations, and psychosis. We...
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
To evaluate the long-term safety of oxycodone-hydrochloride and sequestered naltrexone-hydrochloride (ALO-02) administered for up to 12 months.
The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
To investigate whether treatment differences exist in male and female patients with moderate to severe acne treated with clindamycin phosphate 1.2%/BP 3.75% gel or vehicle as monotherapy.